Patents by Inventor Florence JOLY

Florence JOLY has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Proteins of the WNT signaling pathway and uses thereof in the diagnostic and treatment of hypopigmentation disorders
    Patent number: 11650214
    Abstract: The present invention relates to the identification of proteins of the WNT signaling pathway as therapeutic targets of pigmentation disorder and as biomarkers of pigmentation status. The invention in particular relates to products and methods for treating a hypopigmentation disorder. The invention also relates to products and methods for detecting, diagnosing, staging or monitoring the course of hypopigmentation disorder and is particularly suited for human subjects.
    Type: Grant
    Filed: December 9, 2020
    Date of Patent: May 16, 2023
    Assignees: INSERM (Institut National de la Santé et de la Recherche Médicale), Université de Côte d'Azur, CHU de Nice
    Inventors: Thierry Passeron, Florence Joly
  • PROTEINS OF THE WNT SIGNALING PATHWAY AND USES THEREOF IN THE DIAGNOSTIC AND TREATMENT OF HYPOPIGMENTATION DISORDERS
    Publication number: 20210190800
    Abstract: The present invention relates to the identification of proteins of the WNT signaling pathway as therapeutic targets of pigmentation disorder and as biomarkers of pigmentation status. The invention in particular relates to products and methods for treating a hypopigmentation disorder. The invention also relates to products and methods for detecting, diagnosing, staging or monitoring the course of hypopigmentation disorder and is particularly suited for human subjects.
    Type: Application
    Filed: December 9, 2020
    Publication date: June 24, 2021
    Inventors: Thierry PASSERON, Florence JOLY
  • Proteins of the WNT signaling pathway and uses thereof in the diagnostic and treatment of hypopigmentation disorders
    Patent number: 10983134
    Abstract: The present invention relates to the identification of proteins of the WNT signaling pathway as therapeutic targets of pigmentation disorder and as biomarkers of pigmentation status. The invention in particular relates to products and methods for treating a hypopigmentation disorder. The invention also relates to products and methods for detecting, diagnosing, staging or monitoring the course of hypopigmentation disorder and is particularly suited for human subjects.
    Type: Grant
    Filed: December 16, 2015
    Date of Patent: April 20, 2021
    Assignees: INSERM (INSTITUT NATIONAL DE LA SANTÉ ET DE LA RECHERCHE MÉDICALE), UNIVERSITÉ CÔTE D'AZUR, CHU DE NICE
    Inventors: Thierry Passeron, Florence Joly
  • GSK3B and uses thereof in the diagnostic and treatment of hypopigmentation disorders
    Patent number: 10632117
    Abstract: The present invention relates to the identification of the glycogen synthase kinase-3 beta (GSK3B or GSK-3P) as a therapeutic target of pigmentation disorder and as biomarker of pigmentation status. The invention in particular relates to products and methods for treating a hypopigmentation disorder. The invention also relates to products and methods for detecting, diagnosing, staging or monitoring the course of hypopigmentation disorder and is particularly suited for human subjects.
    Type: Grant
    Filed: December 16, 2015
    Date of Patent: April 28, 2020
    Assignees: INSERM (INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE), UNIVERSITY DE NICE SOPHIA ANTIPOLIS, CHU DE NICE
    Inventors: Thierry Passeron, Florence Joly
  • GSK3B AND USES THEREOF IN THE DIAGNOSTIC AND TREATMENT OF HYPOPIGMENTATION DISORDERS
    Publication number: 20190175594
    Abstract: The present invention relates to the identification of the glycogen synthase kinase-3 beta (GSK3B or GSK-3P) as a therapeutic target of pigmentation disorder and as biomarker of pigmentation status. The invention in particular relates to products and methods for treating a hypopigmentation disorder. The invention also relates to products and methods for detecting, diagnosing, staging or monitoring the course of hypopigmentation disorder and is particularly suited for human subjects.
    Type: Application
    Filed: December 16, 2015
    Publication date: June 13, 2019
    Inventors: Thierry PASSERON, Florence JOLY
  • PROTEINS OF THE WNT SIGNALING PATHWAY AND USES THEREOF IN THE DIAGNOSTIC AND TREATMENT OF HYPOPIGMENTATION DISORDERS
    Publication number: 20180180631
    Abstract: The present invention relates to the identification of proteins of the WNT signaling pathway as therapeutic targets of pigmentation disorder and as biomarkers of pigmentation status. The invention in particular relates to products and methods for treating a hypopigmentation disorder. The invention also relates to products and methods for detecting, diagnosing, staging or monitoring the course of hypopigmentation disorder and is particularly suited for human subjects.
    Type: Application
    Filed: December 16, 2015
    Publication date: June 28, 2018
    Inventors: Thierry PASSERON, Florence JOLY